Quantitative determination of indapamide in pharmaceuticals and urine by high-performance liquid chromatography with amperometric detection

Journal of Chromatographic Science

Volumn 37, Issue 8, 1999, Pages 283-287

  Legorburu, M J ^a   Alonso, R M ^a   Jimenez R M ^a   Ortiz, E ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; DRUG; INDAPAMIDE;

ADULT; ARTICLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; PH; URINE;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIURETICS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTENSION; INDAPAMIDE; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS;

EID: 0033174919     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/37.8.283     Document Type: Article

References (29)

1. D.B. Campbell and R.A. Moore. The pharmacology and clinical pharmacology of indapamide. Postgrad. Med. J. 57(supplement 2): 7-17 (1981).
2. E. Marmo, E. Lampa, F. Rosatti, L. Berrino, S. Russo, A.R. Romano, and C. Matera. Experimental analysis of antihypertensive properties of 5984 and its constituents: tertatolol and indapamide. Drugs Exp. Clin. Res. 11: 709-715 (1985).
3. C. Rodríguez Bueno, A.F. Rodríguez, D. Carreras, J.I. Maynar, R. Cortes, and M. Maynar. Modificación de las tendencias de abuso de los diferentes tipos de agentes dopantes. Arch. Med. Deporte. 8(32): 411-16 (1991).
4. D.B. Campbell, A.R. Taylor, and R.A. Moore. Observations on the pharmacokinetics of indapamide in man. Brit. J. Clin. Pharmacol. 3: 971P (1976).
5. D.B. Campbell and E.M. Philips. Short term effects and urinary excretion of the new diuretic indapamide, in normal subjects, fur. J. Clin. Pharmacol. 7: 407-414 (1974).
6. P.E. Grebow, J.A. Treitman, and A.K. Yeung. Fluorimetric assay for urinary indapamide. J. Pharm. Sci. 67(8): 1117-20 (1978).
7. P.E. Grebow, J.A. Treitman, A.K. Yeung, and M.M. Johnston. Semiautomated assay for indapamide in biological fluids. J. Pharm. Sci. 70(3): 306-308 (1981).
8. P. Pietta and A. Calatroni. High-performance liquid chromatographic assay for monitoring indapamide and its major metabolite in urine. J. Chromatogr. 228: 377-81 (1982).
9. R.L. Choi, M. Rosenberg, and P.E. Grebow. High-performance liquid chromatographic analysis of indapamide (RCH 2555) in urine, plasma and blood. J. Chromatogr. 230: 181-87 (1982).
10. E. Gaetani, C.F. Laureri, M. Vitto, L. Borghi, G.F. Elia, and A. Novarini. Determinazione dell'indapamide nel plasma mediante HPLC. Boll. Chim. Farm. 125(1): 35-37 (1986).
11. M.J. Legorburu, R.M. Alonso, and R.M. Jiménez. Oxidative behavior of sulfonamidic diuretic bumetanide at carbon paste electrode. Electroanal. 5: 333-38 (1993).
12. M.B. Barroso, R.M. Alonso, and R.M. Jiménez. Electrochemical oxidation of the loop diuretic torasemide. Analyst 119: 2359-62 (1994).
13. M.B. Barroso, R.M. Alonso, and R.M. Jiménez. Electrochemical determination of the loop diuretics piretanide and furosemide in pharmaceutical formulations and urine. Anal. Chim. Acta 305(1-3): 332-39 (1995).
14. M.J. Legorburu, R.M. Alonso, and R.M. Jiménez. Electrochemical oxidation of the diuretic indapamide. Electroanal. 8(3): 280-84 (1996).
15. M.J. Legorburu, R.M. Alonso, and R.M. Jiménez. Voltammetric study of the diuretic xipamide. Bioelectrochem. Bioenerg. 32: 57-66 (1993).
16. M.B. Barroso, R.M. Alonso, and R.M. Jiménez. Quantitative analysis of the loop diuretic torasemide in tablets and human urine by HPLC-EC. J. Liq. Chromatogr. 19(2): 179-86 (1996).
17. M.B. Barroso, R.M. Jimé nez, and R.M. Alonso. High performance liquid chromatography-electrochemical detection applied to monitoring clopamide in human urine and pharmaceutical formulations. J. Liq. Chromatogr. Rel. Technol. 20(4): 637-50 (1997).
18. M.J. Legorburu, R.M. Alonso, and R.M. Jiménez. Determination of the non-thiazide diuretic xipamide in pharmaceuticals and urine by HPLC with amperometric detection. J. Liq. Chromatogr. Rel. Technol. 22(5): 735 (1999).
19. M.B. Barroso, R.M. Alonso, and R.M. Jiménez. Simultaneous determination of the diuretics triamterene and furosemide in pharmaceutical formulations and urine by HPLC-EC. J. Liq. Chromatogr. 19(2): 231-46 (1996).
20. M.B. Barroso, R.M. Jiménez, R.M. Alonso, and E. Ortiz. Determination of piretanide and furosemide in pharmaceuticals and human urine by liquid chromatography with amperometric detection. J. Chromatogr. 675: 303-312 (1996).
21. P.A. Tisdall, T.P. Moyer, and J.P. Anhalt. Liquid chromatographic detection of thiazide diuretics in urine. Clin. Chem. 26(6): 702-706 (1980).
22. R.O. Fullinfaw, R.W. Bury, and R.F.W. Mouds. Liquid chromatographic screening of diuretics in urine. J. Chromatogr. 415: 347-56 (1987).
23. S.F. Cooper, R. Massé, and R.J. Dugal. Comprehensive screening procedure for diuretics in urine by high performance liquid chromatography. J. Chromatogr. 489(1): 65-68 (1989).
24. F. Tsai, L. Lui, and B. Ghang. Analysis of diuretic doping agents by HPLC screening and GC-MSD confirmation. J. Pharm. Biomed. Anal. 9(10-12): 1069-76 (1991).
25. R. Herráez-Hernández, P. Campíns-Falco, and A. Sevillano-Cabeza. Improved screening procedure for diuretics. J. Liq. Chromatogr. 15(12): 2205-2224 (1992).
26. R. Ventura. Desenvolupament de procediments analitics per a la detecció de substàncies d'utilizació prohibida en l'sport: diüretics, probenecida l mesocarb. Doctoral thesis, University of Barcelona, 1994.
27. R. Ventura, T. Nadal, P. Alcalde, J.A. Pascual, and J. Segura. Fast screening methods for diuretics, probenecid and other compounds of doping interest. J. Chromatogr. 655: 233-42 (1993).
28. S.J. Park, H.S. Pyo, Y.J. Kim, M.S. Kim, and J. Park. Systematic analysis of diuretic doping agents by HPLC screening and GC-MS confirmation. J. Anal. Toxicol. 14(2): 84-90 (1990).
29. P. Campíns-Falco, R. Herráez-Hernández, and A. Sevillano-Cabeza. Solid-phase extraction techniques for assay of diuretics in human urine samples. J. Liq. Chromatogr. 14(19): 3575-90 (1991).